Skip to playerSkip to main content
  • 5 years ago
Drugs Controller General of India has given approval to Serum Institute of India, Pune, to conduct Phase 2 and 3 clinical trials of Oxford University-Astra Zeneca,  COVID-19 vaccine in India.

Category

🗞
News
Be the first to comment
Add your comment

Recommended